We also confirmed the rescue of axoplasmic fluidity and ATP levels upon NMN treatment in the SNCA 3× lines from a patient with PD, as well as in the additional TDP-43N390D, TDP-43M337V, and c9orf72 lines from patients with ALS (fig. The gene discussed is C9orf72; the disease is Parkinson disease.